Comparison of oxymetazoline and lidocaine versus cocaine for outpatient dacryocystorhinostomy.
OBJECTIVE
To evaluate the effectiveness of oxymetazoline combined with lidocaine versus cocaine for outpatient dacryocystorhinostomy (DCR).


METHODS
Twenty-seven patients underwent DCR with a combination of oxymetazoline 0.05% nasal spray and lidocaine 4% spray/pledgetts (oxy/lido) and were compared with 28 patients who underwent DCR with cocaine 4% pledgetts for nasal anesthesia and vasoconstriction. Most of the patients underwent standard external approach DCR: five patients in the oxy/lido group and four patients in the cocaine group underwent endoscopic DCR.


RESULTS
Patients in both groups reported being comfortable during and immediately after surgery. Visualization of the operative field was adequate, and surgery was successfully completed in all cases. Mean blood loss was 6.3 ml (+/-6.0) in the oxy/lido group and 7.3 ml (+/-6.4) in the cocaine group (p = 0.541). There were no cases of postoperative epistaxis requiring nasal packing or hospital admission in the oxy/lido group, whereas one patient in the cocaine group developed epistaxis 8 days after surgery, which required treatment. Success rate was similar in the two groups.


CONCLUSIONS
The combination of oxymetazoline and lidocaine is effective for outpatient dacryocystorhinostomy. Patient comfort was adequate and blood loss not significantly different in comparison to cocaine. This combination provides effective nasal anesthesia and vasoconstriction, while avoiding the "hassle" and potentially greater risks associated with cocaine.
Meyer
D R
DR
Department of Ophthalmology, Lions Eye Institute, Albany Medical Center, New York 12208, USA.
D000556:Ambulatory Surgical Procedures; D000772:Anesthesia, Local / Q000379:methods; D019162:Anesthetics, Combined / Q000008:administration & dosage*; D000779:Anesthetics, Local / Q000008:administration & dosage*; D003042:Cocaine / Q000008:administration & dosage*; D003608:Dacryocystorhinostomy; D006801:Humans; D008012:Lidocaine / Q000008:administration & dosage*; D009301:Nasolacrimal Duct / Q000601:surgery; D009330:Nebulizers and Vaporizers; D010109:Oxymetazoline / Q000008:administration & dosage*; D014662:Vasoconstrictor Agents / Q000008:administration & dosage*
D019162:Anesthetics, Combined; D000779:Anesthetics, Local; D014662:Vasoconstrictor Agents; D010109:Oxymetazoline; D008012:Lidocaine; D003042:Cocaine